{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:30:27Z","timestamp":1790688627801,"version":"4.1.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA034892"],"award-info":[{"award-number":["DA034892"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA020531"],"award-info":[{"award-number":["DA020531"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00018-018-2955-0","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T10:53:36Z","timestamp":1540810416000},"page":"729-743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Cannabinoid exposure during pregnancy and its impact on immune function"],"prefix":"10.1007","volume":"76","author":[{"given":"Catherine","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Yaragudri","family":"Vinod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralidhar L.","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0949-919X","authenticated-orcid":false,"given":"Venkatesh L.","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"key":"2955_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/YCO.0b013e32812144cc","volume":"20","author":"W Hall","year":"2007","unstructured":"Hall W, Degenhardt L (2007) Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 20:393\u2013397. https:\/\/doi.org\/10.1097\/YCO.0b013e32812144cc","journal-title":"Curr Opin Psychiatry"},{"key":"2955_CR2","unstructured":"NIDA (2018) Drug facts: Marijuana. National Institute on Drug Abuse, Bethesda. https:\/\/www.drugabuse.gov\/publications\/drugfacts\/marijuana . Accessed 31 Aug 2018"},{"key":"2955_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.JAA.0000525914.28344.e2","volume":"30","author":"SA Freund","year":"2017","unstructured":"Freund SA, Banning AS (2017) Synthetic cannabinoids: a review of the clinical implications of a new drug of choice. JAAPA 30:1\u20134. https:\/\/doi.org\/10.1097\/01.JAA.0000525914.28344.e2","journal-title":"JAAPA"},{"key":"2955_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3109\/07853890.2016.1145794","volume":"48","author":"RJ Schrot","year":"2016","unstructured":"Schrot RJ, Hubbard JR (2016) Cannabinoids: medical implications. Ann Med 48:128\u2013141. https:\/\/doi.org\/10.3109\/07853890.2016.1145794","journal-title":"Ann Med"},{"key":"2955_CR5","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1001\/jama.2015.6199","volume":"313","author":"KP Hill","year":"2015","unstructured":"Hill KP (2015) Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA 313:2474\u20132483. https:\/\/doi.org\/10.1001\/jama.2015.6199","journal-title":"JAMA"},{"key":"2955_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nrn2253","volume":"8","author":"RM Murray","year":"2007","unstructured":"Murray RM, Morrison PD, Henquet C, Di Forti M (2007) Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 8:885\u2013895. https:\/\/doi.org\/10.1038\/nrn2253","journal-title":"Nat Rev Neurosci"},{"key":"2955_CR7","first-page":"90","volume":"109","author":"DM Svrakic","year":"2012","unstructured":"Svrakic DM, Lustman PJ, Mallya A et al (2012) Legalization, decriminalization and medicinal use of cannabis: a scientific and public health perspective. Mol Med 109:90\u201398","journal-title":"Mol Med"},{"key":"2955_CR8","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1046\/j.1360-0443.1996.911115852.x","volume":"91","author":"IB Adams","year":"1996","unstructured":"Adams IB, Martin BR (1996) Cannabis: pharmacology and toxicology in animals and humans. Addiction 91:1585\u20131614. https:\/\/doi.org\/10.1046\/j.1360-0443.1996.911115852.x","journal-title":"Addiction"},{"key":"2955_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","volume":"78","author":"MA ElSohly","year":"2005","unstructured":"ElSohly MA, Slade D (2005) Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 78:539\u2013548. https:\/\/doi.org\/10.1016\/j.lfs.2005.09.011","journal-title":"Life Sci"},{"key":"2955_CR10","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.2174\/138161212802884681","volume":"18","author":"AW Zuardi","year":"2012","unstructured":"Zuardi AW, Crippa JAS, Hallak JEC et al (2012) A critical review of the antipsychotic effects of cannabidiol: 30\u00a0years of a translational investigation. Curr Pharm Des 18:5131\u20135140","journal-title":"Curr Pharm Des"},{"key":"2955_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1146\/annurev.med.57.011205.135648","volume":"57","author":"V Di Marzo","year":"2006","unstructured":"Di Marzo V, Petrocellis LD (2006) Plant, synthetic, and endogenous cannabinoids in medicine. Annu Rev Med 57:553\u2013574. https:\/\/doi.org\/10.1146\/annurev.med.57.011205.135648","journal-title":"Annu Rev Med"},{"key":"2955_CR12","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1056\/NEJMra1407304","volume":"373","author":"D Friedman","year":"2015","unstructured":"Friedman D, Devinsky O (2015) Cannabinoids in the treatment of epilepsy. N Engl J Med 373:1048\u20131058. https:\/\/doi.org\/10.1056\/NEJMra1407304","journal-title":"N Engl J Med"},{"key":"2955_CR13","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","volume":"367","author":"RG Pertwee","year":"2012","unstructured":"Pertwee RG (2012) Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond B Biol Sci 367:3353\u20133363. https:\/\/doi.org\/10.1098\/rstb.2011.0381","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2955_CR14","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.4155\/fmc.09.93","volume":"1","author":"P Nagarkatti","year":"2009","unstructured":"Nagarkatti P, Pandey R, Rieder SA et al (2009) Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 1:1333\u20131349. https:\/\/doi.org\/10.4155\/fmc.09.93","journal-title":"Future Med Chem"},{"key":"2955_CR15","unstructured":"WHO (2016) Management of substance abuse: Cannabis. World Health Organisation. http:\/\/www.who.int\/substance_abuse\/facts\/cannabis\/en.2016 . Accessed 31 Aug 2018"},{"key":"2955_CR16","volume-title":"Monitoring the Future national results on adolescent drug use: overview of key findings, 2011","author":"L Johnston","year":"2012","unstructured":"Johnston L, O\u2019Malley P, Bachman J, Schulenberg J (2012) Monitoring the Future national results on adolescent drug use: overview of key findings, 2011. Institute for Social Research, The University of Michigan, Ann Arbor"},{"key":"2955_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6511a1","volume":"65","author":"A Azofeifa","year":"2016","unstructured":"Azofeifa A, Mattson ME, Schauer G et al (2016) National estimates of marijuana use and related indicators\u2014National Survey on Drug Use and Health, United States, 2002\u20132014. MMWR Surveill Summ 65:1\u201328. https:\/\/doi.org\/10.15585\/mmwr.ss6511a1","journal-title":"MMWR Surveill Summ"},{"key":"2955_CR18","unstructured":"SAMHSA (2017) Center for Behavioral Health Statistics and Quality. 2015 National Survey on Drug Use and Health: Methodological resource book (Section\u00a013, Statistical inference report). Substance Abuse and Mental Health Services Administration, Rockville. https:\/\/www.samhsa.gov\/data . Accessed 31 Aug 2018"},{"key":"2955_CR19","unstructured":"NIDA (2018) Drug facts: synthetic cannabinoids (K2\/Spice). National Institute on Drug Abuse. https:\/\/www.drugabuse.gov\/publications\/drugfacts\/synthetic-cannabinoids-k2spice . Accessed 30 Mar 2018"},{"key":"2955_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.drugalcdep.2016.06.002","volume":"165","author":"L-T Wu","year":"2016","unstructured":"Wu L-T, Zhu H, Swartz MS (2016) Trends in cannabis use disorders among racial\/ethnic population groups in the United States. Drug Alcohol Depend 165:181\u2013190. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.06.002","journal-title":"Drug Alcohol Depend"},{"key":"2955_CR21","first-page":"180","volume":"42","author":"MB Bridgeman","year":"2017","unstructured":"Bridgeman MB, Abazia DT (2017) Medicinal cannabis: history, pharmacology, and implications for the acute care setting. P T 42:180\u2013188","journal-title":"P T"},{"key":"2955_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1874473711205010032","volume":"5","author":"F Cascini","year":"2012","unstructured":"Cascini F, Aiello C, Di Tanna G (2012) Increasing delta-9-tetrahydrocannabinol (\u0394-9-THC) content in herbal cannabis over time: systematic review and meta-analysis. Curr Drug Abuse Rev 5:32\u201340","journal-title":"Curr Drug Abuse Rev"},{"key":"2955_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainresbull.2016.04.013","volume":"126","author":"G Loeffler","year":"2016","unstructured":"Loeffler G, Delaney E, Hann M (2016) International trends in spice use: prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids. Brain Res Bull 126:8\u201328. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.04.013","journal-title":"Brain Res Bull"},{"key":"2955_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.drugalcdep.2015.01.044","volume":"149","author":"JJ Palamar","year":"2015","unstructured":"Palamar JJ, Acosta P (2015) Synthetic cannabinoid use in a nationally representative sample of US high school seniors. Drug Alcohol Depend 149:194\u2013202. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.01.044","journal-title":"Drug Alcohol Depend"},{"key":"2955_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fnbeh.2011.00060","volume":"5","author":"L Fattore","year":"2011","unstructured":"Fattore L, Fratta W (2011) Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci 5:60. https:\/\/doi.org\/10.3389\/fnbeh.2011.00060","journal-title":"Front Behav Neurosci"},{"key":"2955_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","volume":"144","author":"MS Castaneto","year":"2014","unstructured":"Castaneto MS, Gorelick DA, Desrosiers NA et al (2014) Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 144:12\u201341. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.08.005","journal-title":"Drug Alcohol Depend"},{"key":"2955_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11920-016-0694-1","volume":"18","author":"ZD Cooper","year":"2016","unstructured":"Cooper ZD (2016) Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal. Curr Psychiatry Rep 18:52. https:\/\/doi.org\/10.1007\/s11920-016-0694-1","journal-title":"Curr Psychiatry Rep"},{"key":"2955_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.14797\/mdcj-11-3-189","volume":"11","author":"VS Gudsoorkar","year":"2015","unstructured":"Gudsoorkar VS, Perez JA (2015) A new differential diagnosis: synthetic cannabinoids-associated acute renal failure. Methodist Debakey Cardiovasc J 11:189\u2013191. https:\/\/doi.org\/10.14797\/mdcj-11-3-189","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"2955_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tips.2016.12.003","volume":"38","author":"BM Ford","year":"2017","unstructured":"Ford BM, Tai S, Fantegrossi WE, Prather PL (2017) Synthetic pot: not your grandfather\u2019s marijuana. Trends Pharmacol Sci 38:257\u2013276. https:\/\/doi.org\/10.1016\/j.tips.2016.12.003","journal-title":"Trends Pharmacol Sci"},{"key":"2955_CR30","first-page":"443","volume":"48","author":"CC Felder","year":"1995","unstructured":"Felder CC, Joyce KE, Briley EM et al (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443\u2013450","journal-title":"Mol Pharmacol"},{"key":"2955_CR31","first-page":"14","volume":"25","author":"F Grotenhermen","year":"2004","unstructured":"Grotenhermen F (2004) Pharmacology of cannabinoids. Neuro Endocrinol Lett 25:14\u201323","journal-title":"Neuro Endocrinol Lett"},{"key":"2955_CR32","unstructured":"Johnston M, O\u2019Malley P, Bachman J (2000) Monitoring the future national survey results on drug use, 1975\u20131999. Volume II: College Students and Adults Ages 19\u201340. National Institute of Drug Abuse, Rockville. http:\/\/www.monitoringthefuture.org\/pubs.html . Accessed 5 Oct 2018"},{"key":"2955_CR33","first-page":"374","volume":"101","author":"SH Ebrahim","year":"2003","unstructured":"Ebrahim SH, Gfroerer J (2003) Pregnancy-related substance use in the United States during 1996\u20131998. Obstet Gynecol 101:374\u2013379","journal-title":"Obstet Gynecol"},{"key":"2955_CR34","unstructured":"Lipari RN, Hedden SL, Hughes A (2013) Substance use and mental health estimates from the 2013 National Survey on Drug Use and Health: Overview of Findings. In: The CBHSQ Report. Substance Abuse and Mental Health Services Administration (US), Rockville"},{"key":"2955_CR35","doi-asserted-by":"publisher","first-page":"e009986","DOI":"10.1136\/bmjopen-2015-009986","volume":"6","author":"JKL Gunn","year":"2016","unstructured":"Gunn JKL, Rosales CB, Center KE et al (2016) Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 6:e009986. https:\/\/doi.org\/10.1136\/bmjopen-2015-009986","journal-title":"BMJ Open"},{"key":"2955_CR36","volume-title":"Results from the 2013 National Survey on Drug Use and Health: summary of national findings","author":"SAMHSA","year":"2014","unstructured":"SAMHSA (2014) Results from the 2013 National Survey on Drug Use and Health: summary of national findings. Substance Abuse and Mental Health Services Administration, Rockville"},{"key":"2955_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/ADM.0000000000000095","volume":"9","author":"CE Martin","year":"2015","unstructured":"Martin CE, Longinaker N, Mark K et al (2015) Recent trends in treatment admissions for marijuana use during pregnancy. J Addict Med 9:99\u2013104. https:\/\/doi.org\/10.1097\/ADM.0000000000000095","journal-title":"J Addict Med"},{"key":"2955_CR38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/AOG.0000000000002429","volume":"131","author":"A Braillon","year":"2018","unstructured":"Braillon A, Bewley S (2018) Committee Opinion No. 722: marijuana use during pregnancy and lactation. Obstet Gynecol 131:164. https:\/\/doi.org\/10.1097\/AOG.0000000000002429","journal-title":"Obstet Gynecol"},{"key":"2955_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1515\/revneuro-2017-0052","volume":"29","author":"A Brancato","year":"2018","unstructured":"Brancato A, Cannizzaro C (2018) Mothering under the influence: how perinatal drugs of abuse alter the mother\u2013infant interaction. Rev Neurosci 29:283\u2013294. https:\/\/doi.org\/10.1515\/revneuro-2017-0052","journal-title":"Rev Neurosci"},{"key":"2955_CR40","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.biopsych.2015.09.009","volume":"79","author":"A Alp\u00e1r","year":"2016","unstructured":"Alp\u00e1r A, Di Marzo V, Harkany T (2016) At the tip of an iceberg: prenatal marijuana and its possible relation to neuropsychiatric outcome in the offspring. Biol Psychiatry 79:e33\u2013e45. https:\/\/doi.org\/10.1016\/j.biopsych.2015.09.009","journal-title":"Biol Psychiatry"},{"key":"2955_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0074-7742(09)85009-5","volume":"85","author":"P Campolongo","year":"2009","unstructured":"Campolongo P, Trezza V, Palmery M et al (2009) Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. Int Rev Neurobiol 85:117\u2013133. https:\/\/doi.org\/10.1016\/S0074-7742(09)85009-5","journal-title":"Int Rev Neurobiol"},{"key":"2955_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/pr.2011.25","volume":"71","author":"MR Hayatbakhsh","year":"2012","unstructured":"Hayatbakhsh MR, Flenady VJ, Gibbons KS et al (2012) Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res 71:215\u2013219. https:\/\/doi.org\/10.1038\/pr.2011.25","journal-title":"Pediatr Res"},{"key":"2955_CR43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00406-009-0027-z","volume":"259","author":"D Jutras-Aswad","year":"2009","unstructured":"Jutras-Aswad D, DiNieri JA, Harkany T, Hurd YL (2009) Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur Arch Psychiatry Clin Neurosci 259:395\u2013412. https:\/\/doi.org\/10.1007\/s00406-009-0027-z","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2955_CR44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.biopsych.2004.10.015","volume":"56","author":"X Wang","year":"2004","unstructured":"Wang X, Dow-Edwards D, Anderson V et al (2004) In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus. Biol Psychiatry 56:909\u2013915. https:\/\/doi.org\/10.1016\/j.biopsych.2004.10.015","journal-title":"Biol Psychiatry"},{"key":"2955_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jneumeth.2016.09.010","volume":"274","author":"A Brancato","year":"2016","unstructured":"Brancato A, Lavanco G, Cavallaro A et al (2016) The use of the emotional-object recognition as an assay to assess learning and memory associated to an aversive stimulus in rodents. J Neurosci Methods 274:106\u2013115. https:\/\/doi.org\/10.1016\/j.jneumeth.2016.09.010","journal-title":"J Neurosci Methods"},{"key":"2955_CR46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/0269881117725683","volume":"32","author":"A Brancato","year":"2018","unstructured":"Brancato A, Cavallaro A, Lavanco G et al (2018) Reward-related limbic memory and stimulation of the cannabinoid system: an upgrade in value attribution? J Psychopharmacol (Oxford) 32:204\u2013214. https:\/\/doi.org\/10.1177\/0269881117725683","journal-title":"J Psychopharmacol (Oxford)"},{"key":"2955_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1471-0528.2002.01020.x","volume":"109","author":"DM Fergusson","year":"2002","unstructured":"Fergusson DM, Horwood LJ, Northstone K, ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood (2002) Maternal use of cannabis and pregnancy outcome. BJOG 109:21\u201327","journal-title":"BJOG"},{"key":"2955_CR48","doi-asserted-by":"publisher","first-page":"478.e1","DOI":"10.1016\/j.ajog.2017.05.050","volume":"217","author":"TD Metz","year":"2017","unstructured":"Metz TD, Allshouse AA, Hogue CJ et al (2017) Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity. Am J Obstet Gynecol 217:478.e1\u2013478.e8. https:\/\/doi.org\/10.1016\/j.ajog.2017.05.050","journal-title":"Am J Obstet Gynecol"},{"key":"2955_CR49","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/sj.bjp.0705666","volume":"141","author":"L De Petrocellis","year":"2004","unstructured":"De Petrocellis L, Cascio MG, Di Marzo V (2004) The endocannabinoid system: a general view and latest additions. Br J Pharmacol 141:765\u2013774. https:\/\/doi.org\/10.1038\/sj.bjp.0705666","journal-title":"Br J Pharmacol"},{"key":"2955_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0165-6147(94)90106-6","volume":"15","author":"WA Devane","year":"1994","unstructured":"Devane WA (1994) New dawn of cannabinoid pharmacology. Trends Pharmacol Sci 15:40\u201341","journal-title":"Trends Pharmacol Sci"},{"key":"2955_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(98)00649-9","volume":"359","author":"R Mechoulam","year":"1998","unstructured":"Mechoulam R, Fride E, Di Marzo V (1998) Endocannabinoids. Eur J Pharmacol 359:1\u201318","journal-title":"Eur J Pharmacol"},{"key":"2955_CR52","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s12035-012-8299-0","volume":"46","author":"A Luchicchi","year":"2012","unstructured":"Luchicchi A, Pistis M (2012) Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. Mol Neurobiol 46:374\u2013392. https:\/\/doi.org\/10.1007\/s12035-012-8299-0","journal-title":"Mol Neurobiol"},{"key":"2955_CR53","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","volume":"14","author":"JL Blankman","year":"2007","unstructured":"Blankman JL, Simon GM, Cravatt BF (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14:1347\u20131356. https:\/\/doi.org\/10.1016\/j.chembiol.2007.11.006","journal-title":"Chem Biol"},{"key":"2955_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","volume":"384","author":"BF Cravatt","year":"1996","unstructured":"Cravatt BF, Giang DK, Mayfield SP et al (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83\u201387. https:\/\/doi.org\/10.1038\/384083a0","journal-title":"Nature"},{"key":"2955_CR55","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2741\/3701","volume":"16","author":"M Bari","year":"2011","unstructured":"Bari M, Battista N, Pirazzi V, Maccarrone M (2011) The manifold actions of endocannabinoids on female and male reproductive events. Front Biosci (Landmark Ed) 16:498\u2013516","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2955_CR56","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.cca.2010.03.012","volume":"411","author":"AH Taylor","year":"2010","unstructured":"Taylor AH, Amoako AA, Bambang K et al (2010) Endocannabinoids and pregnancy. Clin Chim Acta 411:921\u2013930. https:\/\/doi.org\/10.1016\/j.cca.2010.03.012","journal-title":"Clin Chim Acta"},{"issue":"Suppl 1","key":"2955_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2826.2008.01684.x","volume":"20","author":"N Battista","year":"2008","unstructured":"Battista N, Pasquariello N, Di Tommaso M, Maccarrone M (2008) Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction. J Neuroendocrinol 20(Suppl 1):82\u201389. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01684.x","journal-title":"J Neuroendocrinol"},{"key":"2955_CR58","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/humupd\/dmm018","volume":"13","author":"AH Taylor","year":"2007","unstructured":"Taylor AH, Ang C, Bell SC, Konje JC (2007) The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum Reprod Update 13:501\u2013513. https:\/\/doi.org\/10.1093\/humupd\/dmm018","journal-title":"Hum Reprod Update"},{"issue":"Suppl 1","key":"2955_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2826.2008.01670.x","volume":"20","author":"E Fride","year":"2008","unstructured":"Fride E (2008) Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development. J Neuroendocrinol 20(Suppl 1):75\u201381. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01670.x","journal-title":"J Neuroendocrinol"},{"key":"2955_CR60","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/S0140-6736(00)02115-2","volume":"355","author":"M Maccarrone","year":"2000","unstructured":"Maccarrone M, Valensise H, Bari M et al (2000) Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 355:1326\u20131329. https:\/\/doi.org\/10.1016\/S0140-6736(00)02115-2","journal-title":"Lancet"},{"key":"2955_CR61","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/molehr\/8.2.188","volume":"8","author":"M Maccarrone","year":"2002","unstructured":"Maccarrone M, Bisogno T, Valensise H et al (2002) Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod 8:188\u2013195","journal-title":"Mol Hum Reprod"},{"key":"2955_CR62","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1210\/en.2007-1799","volume":"149","author":"OMH Habayeb","year":"2008","unstructured":"Habayeb OMH, Taylor AH, Bell SC et al (2008) Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Endocrinology 149:5052\u20135060. https:\/\/doi.org\/10.1210\/en.2007-1799","journal-title":"Endocrinology"},{"key":"2955_CR63","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.tips.2004.05.002","volume":"25","author":"M Maccarrone","year":"2004","unstructured":"Maccarrone M, Finazzi-Agr\u00f2 A (2004) Anandamide hydrolase: a guardian angel of human reproduction? Trends Pharmacol Sci 25:353\u2013357. https:\/\/doi.org\/10.1016\/j.tips.2004.05.002","journal-title":"Trends Pharmacol Sci"},{"key":"2955_CR64","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1073\/pnas.94.8.4188","volume":"94","author":"PC Schmid","year":"1997","unstructured":"Schmid PC, Paria BC, Krebsbach RJ et al (1997) Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc Natl Acad Sci USA 94:4188\u20134192","journal-title":"Proc Natl Acad Sci USA"},{"key":"2955_CR65","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1530\/REP-16-0364","volume":"152","author":"M Almada","year":"2016","unstructured":"Almada M, Amaral C, Diniz-da-Costa M et al (2016) The endocannabinoid anandamide impairs in vitro decidualization of human cells. Reproduction 152:351\u2013361. https:\/\/doi.org\/10.1530\/REP-16-0364","journal-title":"Reproduction"},{"key":"2955_CR66","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mce.2015.04.024","volume":"411","author":"BM Fonseca","year":"2015","unstructured":"Fonseca BM, Correia-da-Silva G, Teixeira NA (2015) Anandamide restricts uterine stromal differentiation and is critical for complete decidualization. Mol Cell Endocrinol 411:167\u2013176. https:\/\/doi.org\/10.1016\/j.mce.2015.04.024","journal-title":"Mol Cell Endocrinol"},{"key":"2955_CR67","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/mrd.90021","volume":"63","author":"H Schuel","year":"2002","unstructured":"Schuel H, Burkman LJ, Lippes J et al (2002) Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol Reprod Dev 63:376\u2013387. https:\/\/doi.org\/10.1002\/mrd.90021","journal-title":"Mol Reprod Dev"},{"key":"2955_CR68","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1194\/jlr.M082644","volume":"59","author":"AL McIntosh","year":"2018","unstructured":"McIntosh AL, Martin GG, Huang H et al (2018) \u03949-Tetrahydrocannabinol induces endocannabinoid accumulation in mouse hepatocytes: antagonism by Fabp1 gene ablation. J Lipid Res 59:646\u2013657. https:\/\/doi.org\/10.1194\/jlr.M082644","journal-title":"J Lipid Res"},{"key":"2955_CR69","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bbalip.2018.02.001","volume":"1863","author":"E Leishman","year":"2018","unstructured":"Leishman E, Murphy M, Mackie K, Bradshaw HB (2018) \u03949-Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult. Biochim Biophys Acta Mol Cell Biol Lipids 1863:479\u2013492. https:\/\/doi.org\/10.1016\/j.bbalip.2018.02.001","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2955_CR70","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/humupd\/dmq058","volume":"17","author":"T Karasu","year":"2011","unstructured":"Karasu T, Marczylo TH, Maccarrone M, Konje JC (2011) The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility. Hum Reprod Update 17:347\u2013361. https:\/\/doi.org\/10.1093\/humupd\/dmq058","journal-title":"Hum Reprod Update"},{"key":"2955_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jsbmb.2017.07.023","volume":"174","author":"J Maia","year":"2017","unstructured":"Maia J, Almada M, Silva A et al (2017) The endocannabinoid system expression in the female reproductive tract is modulated by estrogen. J Steroid Biochem Mol Biol 174:40\u201347. https:\/\/doi.org\/10.1016\/j.jsbmb.2017.07.023","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2955_CR72","doi-asserted-by":"publisher","first-page":"13318","DOI":"10.1074\/jbc.M211248200","volume":"278","author":"M Maccarrone","year":"2003","unstructured":"Maccarrone M, Di Rienzo M, Finazzi-Agr\u00f2 A, Rossi A (2003) Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3. J Biol Chem 278:13318\u201313324. https:\/\/doi.org\/10.1074\/jbc.M211248200","journal-title":"J Biol Chem"},{"key":"2955_CR73","doi-asserted-by":"publisher","first-page":"32726","DOI":"10.1074\/jbc.M302123200","volume":"278","author":"M Maccarrone","year":"2003","unstructured":"Maccarrone M, Bari M, Di Rienzo M et al (2003) Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin. J Biol Chem 278:32726\u201332732. https:\/\/doi.org\/10.1074\/jbc.M302123200","journal-title":"J Biol Chem"},{"key":"2955_CR74","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.4049\/jimmunol.166.12.7183","volume":"166","author":"M Maccarrone","year":"2001","unstructured":"Maccarrone M, Valensise H, Bari M et al (2001) Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. J Immunol 166:7183\u20137189","journal-title":"J Immunol"},{"key":"2955_CR75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jri.2012.10.003","volume":"96","author":"KN Bambang","year":"2012","unstructured":"Bambang KN, Lambert DG, Lam PMW et al (2012) Immunity and early pregnancy events: are endocannabinoids the missing link? J Reprod Immunol 96:8\u201318. https:\/\/doi.org\/10.1016\/j.jri.2012.10.003","journal-title":"J Reprod Immunol"},{"key":"2955_CR76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/dta.1390","volume":"5","author":"D Psychoyos","year":"2013","unstructured":"Psychoyos D, Vinod KY (2013) Marijuana, Spice \u201cherbal high\u201d, and early neural development: implications for rescheduling and legalization. Drug Test Anal 5:27\u201345. https:\/\/doi.org\/10.1002\/dta.1390","journal-title":"Drug Test Anal"},{"key":"2955_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/bdrb.20348","volume":"95","author":"D Psychoyos","year":"2012","unstructured":"Psychoyos D, Vinod KY, Cao J et al (2012) Cannabinoid receptor 1 signaling in embryo neurodevelopment. Birth Defects Res B Dev Reprod Toxicol 95:137\u2013150. https:\/\/doi.org\/10.1002\/bdrb.20348","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"2955_CR78","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/molehr\/gas049","volume":"19","author":"H-A Oh","year":"2013","unstructured":"Oh H-A, Kwon S, Choi S et al (2013) Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos. Mol Hum Reprod 19:93\u2013101. https:\/\/doi.org\/10.1093\/molehr\/gas049","journal-title":"Mol Hum Reprod"},{"key":"2955_CR79","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/humupd\/dmg026","volume":"9","author":"AL Veenstra van Nieuwenhoven","year":"2003","unstructured":"Veenstra van Nieuwenhoven AL, Heineman MJ, Faas MM (2003) The immunology of successful pregnancy. Hum Reprod Update 9:347\u2013357","journal-title":"Hum Reprod Update"},{"key":"2955_CR80","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/science.270.5236.630","volume":"270","author":"A Tafuri","year":"1995","unstructured":"Tafuri A, Alferink J, M\u00f6ller P et al (1995) T cell awareness of paternal alloantigens during pregnancy. Science 270:630\u2013633","journal-title":"Science"},{"key":"2955_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0039.2004.00170.x","volume":"63","author":"A Trundley","year":"2004","unstructured":"Trundley A, Moffett A (2004) Human uterine leukocytes and pregnancy. Tissue Antigens 63:1\u201312","journal-title":"Tissue Antigens"},{"key":"2955_CR82","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1034\/j.1600-0897.2002.1o041.x","volume":"47","author":"P Luppi","year":"2002","unstructured":"Luppi P, Haluszczak C, Trucco M, Deloia JA (2002) Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol 47:72\u201381","journal-title":"Am J Reprod Immunol"},{"key":"2955_CR83","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1189\/jlb.72.5.874","volume":"72","author":"P Luppi","year":"2002","unstructured":"Luppi P, Haluszczak C, Betters D et al (2002) Monocytes are progressively activated in the circulation of pregnant women. J Leukoc Biol 72:874\u2013884","journal-title":"J Leukoc Biol"},{"key":"2955_CR84","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.humimm.2003.08.342","volume":"64","author":"Y Ueda","year":"2003","unstructured":"Ueda Y, Hagihara M, Okamoto A et al (2003) Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults. Hum Immunol 64:1144\u20131151","journal-title":"Hum Immunol"},{"key":"2955_CR85","first-page":"389","volume":"4","author":"Y Shi","year":"2007","unstructured":"Shi Y, Ling B, Zhou Y et al (2007) Interferon-gamma expression in natural killer cells and natural killer T cells is suppressed in early pregnancy. Cell Mol Immunol 4:389\u2013394","journal-title":"Cell Mol Immunol"},{"key":"2955_CR86","first-page":"446","volume":"180","author":"RD Harbison","year":"1972","unstructured":"Harbison RD, Mantilla-Plata B (1972) Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol. J Pharmacol Exp Ther 180:446\u2013453","journal-title":"J Pharmacol Exp Ther"},{"key":"2955_CR87","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0091-3057(76)90236-7","volume":"4","author":"RM Vardaris","year":"1976","unstructured":"Vardaris RM, Weisz DJ, Fazel A, Rawitch AB (1976) Chronic administration of delta-9-tetrahydrocannabinol to pregnant rats: studies of pup behavior and placental transfer. Pharmacol Biochem Behav 4:249\u2013254","journal-title":"Pharmacol Biochem Behav"},{"key":"2955_CR88","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJM198409203111213","volume":"311","author":"C Blackard","year":"1984","unstructured":"Blackard C, Tennes K (1984) Human placental transfer of cannabinoids. N Engl J Med 311:797. https:\/\/doi.org\/10.1056\/NEJM198409203111213","journal-title":"N Engl J Med"},{"key":"2955_CR89","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0041-008X(87)90338-3","volume":"90","author":"JR Bailey","year":"1987","unstructured":"Bailey JR, Cunny HC, Paule MG, Slikker W (1987) Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. Toxicol Appl Pharmacol 90:315\u2013321","journal-title":"Toxicol Appl Pharmacol"},{"key":"2955_CR90","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/CHI.0b013e3181bfa8ee","volume":"48","author":"H El Marroun","year":"2009","unstructured":"El Marroun H, Tiemeier H, Steegers EAP et al (2009) Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. J Am Acad Child Adolesc Psychiatry 48:1173\u20131181. https:\/\/doi.org\/10.1097\/CHI.0b013e3181bfa8ee","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2955_CR91","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ntt.2004.11.002","volume":"27","author":"YL Hurd","year":"2005","unstructured":"Hurd YL, Wang X, Anderson V et al (2005) Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol Teratol 27:221\u2013229. https:\/\/doi.org\/10.1016\/j.ntt.2004.11.002","journal-title":"Neurotoxicol Teratol"},{"key":"2955_CR92","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/BF02738892","volume":"3","author":"LL Murphy","year":"1995","unstructured":"Murphy LL, Gher J, Szary A (1995) Effects of prenatal exposure to delta-9-tetrahydrocannabinol on reproductive, endocrine and immune parameters of male and female rat offspring. Endocrine 3:875\u2013879. https:\/\/doi.org\/10.1007\/BF02738892","journal-title":"Endocrine"},{"key":"2955_CR93","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11481-015-9615-z","volume":"10","author":"GA Cabral","year":"2015","unstructured":"Cabral GA, Rogers TJ, Lichtman AH (2015) Turning over a new leaf: cannabinoid and endocannabinoid modulation of immune function. J Neuroimmune Pharmacol 10:193\u2013203. https:\/\/doi.org\/10.1007\/s11481-015-9615-z","journal-title":"J Neuroimmune Pharmacol"},{"key":"2955_CR94","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0009-3084(02)00159-7","volume":"121","author":"MD Roth","year":"2002","unstructured":"Roth MD, Baldwin GC, Tashkin DP (2002) Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem Phys Lipids 121:229\u2013239","journal-title":"Chem Phys Lipids"},{"key":"2955_CR95","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/0006-2952(96)00480-7","volume":"52","author":"NE Kaminski","year":"1996","unstructured":"Kaminski NE (1996) Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression. Biochem Pharmacol 52:1133\u20131140","journal-title":"Biochem Pharmacol"},{"key":"2955_CR96","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1189\/jlb.0303101","volume":"74","author":"TW Klein","year":"2003","unstructured":"Klein TW, Newton C, Larsen K et al (2003) The cannabinoid system and immune modulation. J Leukoc Biol 74:486\u2013496. https:\/\/doi.org\/10.1189\/jlb.0303101","journal-title":"J Leukoc Biol"},{"key":"2955_CR97","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","volume":"232","author":"S Gali\u00e8gue","year":"1995","unstructured":"Gali\u00e8gue S, Mary S, Marchand J et al (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54\u201361","journal-title":"Eur J Biochem"},{"key":"2955_CR98","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/0166-2236(90)90124-S","volume":"13","author":"AC Howlett","year":"1990","unstructured":"Howlett AC, Bidaut-Russell M, Devane WA et al (1990) The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci 13:420\u2013423","journal-title":"Trends Neurosci"},{"key":"2955_CR99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61\u201365. https:\/\/doi.org\/10.1038\/365061a0","journal-title":"Nature"},{"key":"2955_CR100","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0002-9378(99)70583-1","volume":"181","author":"SP Kenney","year":"1999","unstructured":"Kenney SP, Kekuda R, Prasad PD et al (1999) Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta. Am J Obstet Gynecol 181:491\u2013497","journal-title":"Am J Obstet Gynecol"},{"key":"2955_CR101","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ajog.2003.07.013","volume":"190","author":"MC Dennedy","year":"2004","unstructured":"Dennedy MC, Friel AM, Houlihan DD et al (2004) Cannabinoids and the human uterus during pregnancy. Am J Obstet Gynecol 190:2\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2003.07.013","journal-title":"Am J Obstet Gynecol"},{"key":"2955_CR102","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1073\/pnas.92.10.4332","volume":"92","author":"SK Das","year":"1995","unstructured":"Das SK, Paria BC, Chakraborty I, Dey SK (1995) Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci USA 92:4332\u20134336","journal-title":"Proc Natl Acad Sci USA"},{"key":"2955_CR103","doi-asserted-by":"publisher","first-page":"e4579","DOI":"10.1371\/journal.pone.0004579","volume":"4","author":"MR El-Talatini","year":"2009","unstructured":"El-Talatini MR, Taylor AH, Elson JC et al (2009) Localisation and function of the endocannabinoid system in the human ovary. PLoS One 4:e4579. https:\/\/doi.org\/10.1371\/journal.pone.0004579","journal-title":"PLoS One"},{"key":"2955_CR104","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/2006","volume":"4","author":"MP Piccinni","year":"1998","unstructured":"Piccinni MP, Beloni L, Livi C et al (1998) Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 4:1020\u20131024. https:\/\/doi.org\/10.1038\/2006","journal-title":"Nat Med"},{"key":"2955_CR105","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF02918503","volume":"15","author":"MP Piccinni","year":"1996","unstructured":"Piccinni MP, Romagnani S (1996) Regulation of fetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines. Immunol Res 15:141\u2013150","journal-title":"Immunol Res"},{"key":"2955_CR106","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jri.2016.05.001","volume":"116","author":"ML Wolfson","year":"2016","unstructured":"Wolfson ML, Muzzio DO, Ehrhardt J et al (2016) Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production. J Reprod Immunol 116:23\u201327. https:\/\/doi.org\/10.1016\/j.jri.2016.05.001","journal-title":"J Reprod Immunol"},{"key":"2955_CR107","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000026416","volume":"7","author":"I del Arco","year":"2000","unstructured":"del Arco I, Mu\u00f1oz R, Rodr\u00edguez De Fonseca F et al (2000) Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring. Neuroimmunomodulation 7:16\u201326","journal-title":"Neuroimmunomodulation"},{"key":"2955_CR108","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1124\/jpet.111.181206","volume":"339","author":"C Lombard","year":"2011","unstructured":"Lombard C, Hegde VL, Nagarkatti M, Nagarkatti PS (2011) Perinatal exposure to Delta9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens. J Pharmacol Exp Ther 339:607\u2013617. https:\/\/doi.org\/10.1124\/jpet.111.181206","journal-title":"J Pharmacol Exp Ther"},{"key":"2955_CR109","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1155\/S106474490000020X","volume":"8","author":"JM Miller","year":"2000","unstructured":"Miller JM, Goodridge C (2000) Antenatal marijuana use is unrelated to sexually transmitted infections during pregnancy. Infect Dis Obstet Gynecol 8:155\u2013157. https:\/\/doi.org\/10.1155\/S106474490000020X","journal-title":"Infect Dis Obstet Gynecol"},{"key":"2955_CR110","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1445-5994.1988.tb02232.x","volume":"18","author":"B Tindall","year":"1988","unstructured":"Tindall B, Cooper DA, Donovan B et al (1988) The Sydney AIDS Project: development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men. Aust N Z J Med 18:8\u201315","journal-title":"Aust N Z J Med"},{"key":"2955_CR111","doi-asserted-by":"publisher","first-page":"82S","DOI":"10.1002\/j.1552-4604.2002.tb06007.x","volume":"42","author":"BM Bredt","year":"2002","unstructured":"Bredt BM, Higuera-Alhino D, Shade SB et al (2002) Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. J Clin Pharmacol 42:82S\u201389S","journal-title":"J Clin Pharmacol"},{"key":"2955_CR112","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1047-2797(96)00022-1","volume":"6","author":"MJ Di Franco","year":"1996","unstructured":"Di Franco MJ, Sheppard HW, Hunter DJ et al (1996) The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men\u2019s Health Study. Ann Epidemiol 6:283\u2013289","journal-title":"Ann Epidemiol"},{"key":"2955_CR113","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7326\/0003-4819-139-4-200308190-00008","volume":"139","author":"DI Abrams","year":"2003","unstructured":"Abrams DI, Hilton JF, Leiser RJ et al (2003) Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med 139:258\u2013266","journal-title":"Ann Intern Med"},{"key":"2955_CR114","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-4615-5347-2_25","volume":"437","author":"SN Noe","year":"1998","unstructured":"Noe SN, Nyland SB, Ugen K et al (1998) Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN. Adv Exp Med Biol 437:223\u2013229","journal-title":"Adv Exp Med Biol"},{"key":"2955_CR115","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jneuroim.2003.10.026","volume":"147","author":"PK Peterson","year":"2004","unstructured":"Peterson PK, Gekker G, Hu S et al (2004) Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures. J Neuroimmunol 147:123\u2013126","journal-title":"J Neuroimmunol"},{"key":"2955_CR116","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11481-006-9040-4","volume":"2","author":"RB Rock","year":"2007","unstructured":"Rock RB, Gekker G, Hu S et al (2007) WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. J Neuroimmune Pharmacol 2:178\u2013183. https:\/\/doi.org\/10.1007\/s11481-006-9040-4","journal-title":"J Neuroimmune Pharmacol"},{"key":"2955_CR117","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.lfs.2005.05.014","volume":"77","author":"MD Roth","year":"2005","unstructured":"Roth MD, Tashkin DP, Whittaker KM et al (2005) Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse. Life Sci 77:1711\u20131722. https:\/\/doi.org\/10.1016\/j.lfs.2005.05.014","journal-title":"Life Sci"},{"key":"2955_CR118","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/QAD.0000000000001704","volume":"32","author":"MD Rizzo","year":"2018","unstructured":"Rizzo MD, Crawford RB, Henriquez JE et al (2018) HIV-infected cannabis users have lower circulating CD16+ monocytes and IFN-\u03b3-inducible protein 10 levels compared with nonusing HIV patients. AIDS 32:419\u2013429. https:\/\/doi.org\/10.1097\/QAD.0000000000001704","journal-title":"AIDS"},{"key":"2955_CR119","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cgh.2007.10.021","volume":"6","author":"JH Ishida","year":"2008","unstructured":"Ishida JH, Peters MG, Jin C et al (2008) Influence of cannabis use on severity of hepatitis C disease. Clin Gastroenterol Hepatol 6:69\u201375. https:\/\/doi.org\/10.1016\/j.cgh.2007.10.021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2955_CR120","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/hep.20733","volume":"42","author":"C H\u00e9zode","year":"2005","unstructured":"H\u00e9zode C, Roudot-Thoraval F, Nguyen S et al (2005) Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology 42:63\u201371. https:\/\/doi.org\/10.1002\/hep.20733","journal-title":"Hepatology"},{"key":"2955_CR121","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nm1421","volume":"12","author":"F Teixeira-Clerc","year":"2006","unstructured":"Teixeira-Clerc F, Julien B, Grenard P et al (2006) CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 12:671\u2013676. https:\/\/doi.org\/10.1038\/nm1421","journal-title":"Nat Med"},{"key":"2955_CR122","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12967","author":"G Lavanco","year":"2018","unstructured":"Lavanco G, Castelli V, Brancato A et al (2018) The endocannabinoid-alcohol crosstalk: recent advances on a bi-faceted target. Clin Exp Pharmacol Physiol. https:\/\/doi.org\/10.1111\/1440-1681.12967","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2955_CR123","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1126\/science.1142265","volume":"316","author":"M Karsak","year":"2007","unstructured":"Karsak M, Gaffal E, Date R et al (2007) Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316:1494\u20131497. https:\/\/doi.org\/10.1126\/science.1142265","journal-title":"Science"},{"key":"2955_CR124","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1124\/mol.108.047035","volume":"74","author":"VL Hegde","year":"2008","unstructured":"Hegde VL, Hegde S, Cravatt BF et al (2008) Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol Pharmacol 74:20\u201333. https:\/\/doi.org\/10.1124\/mol.108.047035","journal-title":"Mol Pharmacol"},{"key":"2955_CR125","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0083-6729(09)81019-4","volume":"81","author":"R Pandey","year":"2009","unstructured":"Pandey R, Hegde VL, Singh NP et al (2009) Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis. Vitam Horm 81:487\u2013504. https:\/\/doi.org\/10.1016\/S0083-6729(09)81019-4","journal-title":"Vitam Horm"},{"key":"2955_CR126","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.tips.2010.05.006","volume":"31","author":"M Nagarkatti","year":"2010","unstructured":"Nagarkatti M, Rieder SA, Hegde VL et al (2010) Do cannabinoids have a therapeutic role in transplantation? Trends Pharmacol Sci 31:345\u2013350. https:\/\/doi.org\/10.1016\/j.tips.2010.05.006","journal-title":"Trends Pharmacol Sci"},{"key":"2955_CR127","doi-asserted-by":"publisher","first-page":"e18281","DOI":"10.1371\/journal.pone.0018281","volume":"6","author":"VL Hegde","year":"2011","unstructured":"Hegde VL, Nagarkatti PS, Nagarkatti M (2011) Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PLoS One 6:e18281. https:\/\/doi.org\/10.1371\/journal.pone.0018281","journal-title":"PLoS One"},{"key":"2955_CR128","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1124\/jpet.111.182717","volume":"338","author":"R Pandey","year":"2011","unstructured":"Pandey R, Hegde VL, Nagarkatti M, Nagarkatti PS (2011) Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model. J Pharmacol Exp Ther 338:819\u2013828. https:\/\/doi.org\/10.1124\/jpet.111.182717","journal-title":"J Pharmacol Exp Ther"},{"key":"2955_CR129","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.autrev.2016.02.008","volume":"15","author":"V Katchan","year":"2016","unstructured":"Katchan V, David P, Shoenfeld Y (2016) Cannabinoids and autoimmune diseases: a systematic review. Autoimmun Rev 15:513\u2013528. https:\/\/doi.org\/10.1016\/j.autrev.2016.02.008","journal-title":"Autoimmun Rev"},{"key":"2955_CR130","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/sj.bjp.0707458","volume":"152","author":"D Baker","year":"2007","unstructured":"Baker D, Jackson SJ, Pryce G (2007) Cannabinoid control of neuroinflammation related to multiple sclerosis. Br J Pharmacol 152:649\u2013654. https:\/\/doi.org\/10.1038\/sj.bjp.0707458","journal-title":"Br J Pharmacol"},{"key":"2955_CR131","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2174\/138920012800166607","volume":"13","author":"R Antonucci","year":"2012","unstructured":"Antonucci R, Zaffanello M, Puxeddu E et al (2012) Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab 13:474\u2013490","journal-title":"Curr Drug Metab"},{"key":"2955_CR132","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","volume":"327","author":"D-K Li","year":"2003","unstructured":"Li D-K, Liu L, Odouli R (2003) Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 327:368. https:\/\/doi.org\/10.1136\/bmj.327.7411.368","journal-title":"BMJ"},{"key":"2955_CR133","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1503\/cmaj.110454","volume":"183","author":"HR Nakhai-Pour","year":"2011","unstructured":"Nakhai-Pour HR, Broy P, Sheehy O, B\u00e9rard A (2011) Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ 183:1713\u20131720. https:\/\/doi.org\/10.1503\/cmaj.110454","journal-title":"CMAJ"},{"key":"2955_CR134","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1479-828X.1994.tb01086.x","volume":"34","author":"IR Young","year":"1994","unstructured":"Young IR, Thorburn GD (1994) Prostaglandin E2, fetal maturation and ovine parturition. Aust N Z J Obstet Gynaecol 34:342\u2013346","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2955_CR135","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1345\/aph.1G428","volume":"40","author":"G Koren","year":"2006","unstructured":"Koren G, Florescu A, Costei AM et al (2006) Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 40:824\u2013829. https:\/\/doi.org\/10.1345\/aph.1G428","journal-title":"Ann Pharmacother"},{"key":"2955_CR136","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/01480545.2016.1212365","volume":"40","author":"M Hahn","year":"2017","unstructured":"Hahn M, Baierle M, Char\u00e3o MF et al (2017) Polyphenol-rich food general and on pregnancy effects: a review. Drug Chem Toxicol 40:368\u2013374. https:\/\/doi.org\/10.1080\/01480545.2016.1212365","journal-title":"Drug Chem Toxicol"},{"key":"2955_CR137","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5935\/abc.20130166","volume":"101","author":"P Zielinsky","year":"2013","unstructured":"Zielinsky P, Piccoli AL, Vian I et al (2013) Maternal restriction of polyphenols and fetal ductal dynamics in normal pregnancy: an open clinical trial. Arq Bras Cardiol 101:217\u2013225. https:\/\/doi.org\/10.5935\/abc.20130166","journal-title":"Arq Bras Cardiol"},{"key":"2955_CR138","doi-asserted-by":"publisher","DOI":"10.1002\/uog.18974","author":"I Vian","year":"2017","unstructured":"Vian I, Zielinsky P, Z\u00edlio AM et al (2017) Increase of prostaglandin E2 in the reversal of ductal constriction after polyphenol restriction. Ultrasound Obstet Gynecol. https:\/\/doi.org\/10.1002\/uog.18974","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2955_CR139","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0027-5107(98)00027-X","volume":"403","author":"MM Ammenheuser","year":"1998","unstructured":"Ammenheuser MM, Berenson AB, Babiak AE et al (1998) Frequencies of hprt mutant lymphocytes in marijuana-smoking mothers and their newborns. Mutat Res 403:55\u201364","journal-title":"Mutat Res"},{"key":"2955_CR140","doi-asserted-by":"publisher","first-page":"573.e1","DOI":"10.1016\/j.ajog.2013.08.005","volume":"209","author":"V Feinshtein","year":"2013","unstructured":"Feinshtein V, Erez O, Ben-Zvi Z et al (2013) Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study. Am J Obstet Gynecol 209:573.e1\u2013573.e15. https:\/\/doi.org\/10.1016\/j.ajog.2013.08.005","journal-title":"Am J Obstet Gynecol"},{"key":"2955_CR141","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/1097-0142(19890515)63:10<1904::AID-CNCR2820631006>3.0.CO;2-W","volume":"63","author":"LL Robison","year":"1989","unstructured":"Robison LL, Buckley JD, Daigle AE et al (1989) Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer 63:1904\u20131911","journal-title":"Cancer"},{"key":"2955_CR142","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00051316","volume":"4","author":"S Grufferman","year":"1993","unstructured":"Grufferman S, Schwartz AG, Ruymann FB, Maurer HM (1993) Parents\u2019 use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control 4:217\u2013224","journal-title":"Cancer Causes Control"},{"key":"2955_CR143","first-page":"2608","volume":"50","author":"RR Kuijten","year":"1990","unstructured":"Kuijten RR, Bunin GR, Nass CC, Meadows AT (1990) Gestational and familial risk factors for childhood astrocytoma: results of a case\u2013control study. Cancer Res 50:2608\u20132612","journal-title":"Cancer Res"},{"key":"2955_CR144","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1360-0443.2002.00003.x","volume":"97","author":"W Hall","year":"2002","unstructured":"Hall W, MacPhee D (2002) Cannabis use and cancer. Addiction 97:243\u2013247","journal-title":"Addiction"},{"key":"2955_CR145","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10552-005-0580-3","volume":"17","author":"EC Bluhm","year":"2006","unstructured":"Bluhm EC, Daniels J, Pollock BH et al (2006) Maternal use of recreational drugs and neuroblastoma in offspring: a report from the Children\u2019s Oncology Group (United States). Cancer Causes Control 17:663\u2013669. https:\/\/doi.org\/10.1007\/s10552-005-0580-3","journal-title":"Cancer Causes Control"},{"key":"2955_CR146","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1520\/JFS13282J","volume":"37","author":"MR Moeller","year":"1992","unstructured":"Moeller MR, Doerr G, Warth S (1992) Simultaneous quantitation of delta-9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH) in serum by GC\/MS using deuterated internal standards and its application to a smoking study and forensic cases. J Forensic Sci 37:969\u2013983","journal-title":"J Forensic Sci"},{"key":"2955_CR147","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-1-60761-459-3_13","volume":"603","author":"CC Frazee","year":"2010","unstructured":"Frazee CC, Kiscoan M, Garg U (2010) Quantitation of total 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in urine and blood using gas chromatography-mass spectrometry (GC\u2013MS). Methods Mol Biol 603:137\u2013144. https:\/\/doi.org\/10.1007\/978-1-60761-459-3_13","journal-title":"Methods Mol Biol"},{"key":"2955_CR148","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/jat\/32.4.292","volume":"32","author":"S Fu","year":"2008","unstructured":"Fu S, Lewis J (2008) Novel automated extraction method for quantitative analysis of urinary 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid (THC-COOH). J Anal Toxicol 32:292\u2013297","journal-title":"J Anal Toxicol"},{"key":"2955_CR149","doi-asserted-by":"publisher","first-page":"178S","DOI":"10.1002\/j.1552-4604.1981.tb02594.x","volume":"21","author":"ME Wall","year":"1981","unstructured":"Wall ME, Perez-Reyes M (1981) The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man. J Clin Pharmacol 21:178S\u2013189S","journal-title":"J Clin Pharmacol"},{"key":"2955_CR150","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"MA Huestis","year":"2007","unstructured":"Huestis MA (2007) Human cannabinoid pharmacokinetics. Chem Biodivers 4:1770\u20131804. https:\/\/doi.org\/10.1002\/cbdv.200790152","journal-title":"Chem Biodivers"},{"key":"2955_CR151","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1373\/clinchem.2008.122119","volume":"55","author":"EW Schwilke","year":"2009","unstructured":"Schwilke EW, Schwope DM, Karschner EL et al (2009) Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clin Chem 55:2180\u20132189. https:\/\/doi.org\/10.1373\/clinchem.2008.122119","journal-title":"Clin Chem"},{"key":"2955_CR152","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/03602532.2013.849268","volume":"46","author":"SM Stout","year":"2014","unstructured":"Stout SM, Cimino NM (2014) Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metab Rev 46:86\u201395. https:\/\/doi.org\/10.3109\/03602532.2013.849268","journal-title":"Drug Metab Rev"},{"key":"2955_CR153","first-page":"149","volume":"7","author":"P Sharma","year":"2012","unstructured":"Sharma P, Murthy P, Bharath MMS (2012) Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iran J Psychiatry 7:149\u2013156","journal-title":"Iran J Psychiatry"},{"key":"2955_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchromb.2018.01.009","volume":"1074\u20131075","author":"C de Mantovani","year":"2018","unstructured":"de Mantovani C, Silva JPE, Forster G et al (2018) Simultaneous accelerated solvent extraction and hydrolysis of 11-nor-\u03949-tetrahydrocannabinol-9-carboxylic acid glucuronide in meconium samples for gas chromatography-mass spectrometry analysis. J Chromatogr B Analyt Technol Biomed Life Sci 1074\u20131075:1\u20137. https:\/\/doi.org\/10.1016\/j.jchromb.2018.01.009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2955_CR155","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1471-4159.2006.03873.x","volume":"98","author":"M Koch","year":"2006","unstructured":"Koch M, Dehghani F, Habazettl I et al (2006) Cannabinoids attenuate norepinephrine-induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N-acetyltransferase activity without involvement of cannabinoid receptors. J Neurochem 98:267\u2013278. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03873.x","journal-title":"J Neurochem"},{"key":"2955_CR156","first-page":"531","volume":"251","author":"SH Burstein","year":"1989","unstructured":"Burstein SH, Audette CA, Doyle SA et al (1989) Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid. J Pharmacol Exp Ther 251:531\u2013535","journal-title":"J Pharmacol Exp Ther"},{"key":"2955_CR157","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1016\/S0040-4020(01)90158-9","volume":"49","author":"MA Tius","year":"1993","unstructured":"Tius MA, Kannangara GSK, Kerr MA, Grace KJS (1993) Halogenated cannabinoid synthesis. Tetrahedron 49:3291\u20133304. https:\/\/doi.org\/10.1016\/S0040-4020(01)90158-9","journal-title":"Tetrahedron"},{"key":"2955_CR158","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1189\/jlb.3RU0115-021R","volume":"97","author":"C Turcotte","year":"2015","unstructured":"Turcotte C, Chouinard F, Lefebvre JS, Flamand N (2015) Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites. J Leukoc Biol 97:1049\u20131070. https:\/\/doi.org\/10.1189\/jlb.3RU0115-021R","journal-title":"J Leukoc Biol"},{"key":"2955_CR159","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.lfs.2008.09.004","volume":"83","author":"JA Stebulis","year":"2008","unstructured":"Stebulis JA, Johnson DR, Rossetti RG et al (2008) Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells. Life Sci 83:666\u2013670. https:\/\/doi.org\/10.1016\/j.lfs.2008.09.004","journal-title":"Life Sci"},{"key":"2955_CR160","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1096\/fj.08-118323","volume":"23","author":"RB Zurier","year":"2009","unstructured":"Zurier RB, Sun Y-P, George KL et al (2009) Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. FASEB J 23:1503\u20131509. https:\/\/doi.org\/10.1096\/fj.08-118323","journal-title":"FASEB J"},{"key":"2955_CR161","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/jps.22354","volume":"100","author":"S Takeda","year":"2011","unstructured":"Takeda S, Jiang R, Aramaki H et al (2011) \u03949-tetrahydrocannabinol and its major metabolite \u03949-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors. J Pharm Sci 100:1206\u20131211. https:\/\/doi.org\/10.1002\/jps.22354","journal-title":"J Pharm Sci"},{"key":"2955_CR162","first-page":"279","volume-title":"Biochemistry and physiology of substance abuse","author":"D Harvey","year":"1991","unstructured":"Harvey D (1991) Metabolism and pharmacokinetics of the cannabinoids. In: Watson RR (ed) Biochemistry and physiology of substance abuse. CRC Press, Boca Raton, pp 279\u2013365"},{"key":"2955_CR163","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/can.2015.0012","volume":"1","author":"I Ujv\u00e1ry","year":"2016","unstructured":"Ujv\u00e1ry I, Hanu\u0161 L (2016) Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy. Cannabis Cannabinoid Res 1:90\u2013101. https:\/\/doi.org\/10.1089\/can.2015.0012","journal-title":"Cannabis Cannabinoid Res"},{"key":"2955_CR164","unstructured":"Mechoulam R, Tchilibon S et al (2010) United States Patent: 7759526\u2014pharmaceutical compositions comprising cannabidiol derivatives. http:\/\/patft.uspto.gov . Accessed 5 Oct 2018"},{"key":"2955_CR165","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1124\/dmd.112.047530","volume":"40","author":"KC Chimalakonda","year":"2012","unstructured":"Chimalakonda KC, Seely KA, Bratton SM et al (2012) Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2\/Spice: identification of novel cannabinoid receptor ligands. Drug Metab Dispos 40:2174\u20132184. https:\/\/doi.org\/10.1124\/dmd.112.047530","journal-title":"Drug Metab Dispos"},{"key":"2955_CR166","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/anatox\/35.7.487","volume":"35","author":"MA ElSohly","year":"2011","unstructured":"ElSohly MA, Gul W, Elsohly KM et al (2011) Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. J Anal Toxicol 35:487\u2013495","journal-title":"J Anal Toxicol"},{"key":"2955_CR167","doi-asserted-by":"publisher","first-page":"e21917","DOI":"10.1371\/journal.pone.0021917","volume":"6","author":"LK Brents","year":"2011","unstructured":"Brents LK, Reichard EE, Zimmerman SM et al (2011) Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One 6:e21917. https:\/\/doi.org\/10.1371\/journal.pone.0021917","journal-title":"PLoS One"},{"key":"2955_CR168","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lfs.2013.09.017","volume":"97","author":"WE Fantegrossi","year":"2014","unstructured":"Fantegrossi WE, Moran JH, Radominska-Pandya A, Prather PL (2014) Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to \u0394(9)-THC: mechanism underlying greater toxicity? Life Sci 97:45\u201354. https:\/\/doi.org\/10.1016\/j.lfs.2013.09.017","journal-title":"Life Sci"},{"key":"2955_CR169","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/7854_2016_60","volume":"32","author":"S Tai","year":"2017","unstructured":"Tai S, Fantegrossi WE (2017) Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites. Curr Top Behav Neurosci 32:249\u2013262. https:\/\/doi.org\/10.1007\/7854_2016_60","journal-title":"Curr Top Behav Neurosci"},{"key":"2955_CR170","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.taap.2013.03.012","volume":"269","author":"M Rajasekaran","year":"2013","unstructured":"Rajasekaran M, Brents LK, Franks LN et al (2013) Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Toxicol Appl Pharmacol 269:100\u2013108. https:\/\/doi.org\/10.1016\/j.taap.2013.03.012","journal-title":"Toxicol Appl Pharmacol"},{"key":"2955_CR171","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature05913","volume":"447","author":"A Bird","year":"2007","unstructured":"Bird A (2007) Perceptions of epigenetics. Nature 447:396\u2013398. https:\/\/doi.org\/10.1038\/nature05913","journal-title":"Nature"},{"key":"2955_CR172","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ceb.2007.04.002","volume":"19","author":"C Martin","year":"2007","unstructured":"Martin C, Zhang Y (2007) Mechanisms of epigenetic inheritance. Curr Opin Cell Biol 19:266\u2013272. https:\/\/doi.org\/10.1016\/j.ceb.2007.04.002","journal-title":"Curr Opin Cell Biol"},{"key":"2955_CR173","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.biopsych.2015.09.014","volume":"79","author":"H Szutorisz","year":"2016","unstructured":"Szutorisz H, Hurd YL (2016) Epigenetic effects of cannabis exposure. Biol Psychiatry 79:586\u2013594. https:\/\/doi.org\/10.1016\/j.biopsych.2015.09.014","journal-title":"Biol Psychiatry"},{"key":"2955_CR174","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11481-015-9586-0","volume":"10","author":"EE Zumbrun","year":"2015","unstructured":"Zumbrun EE, Sido JM, Nagarkatti PS, Nagarkatti M (2015) Epigenetic regulation of immunological alterations following prenatal exposure to marijuana cannabinoids and its long term consequences in offspring. J Neuroimmune Pharmacol 10:245\u2013254. https:\/\/doi.org\/10.1007\/s11481-015-9586-0","journal-title":"J Neuroimmune Pharmacol"},{"key":"2955_CR175","doi-asserted-by":"publisher","first-page":"36810","DOI":"10.1074\/jbc.M113.503037","volume":"288","author":"VL Hegde","year":"2013","unstructured":"Hegde VL, Tomar S, Jackson A et al (2013) Distinct MicroRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by \u03949-tetrahydrocannabinol in vivo regulation of CCAAT\/enhancer-binding protein \u03b1 by microRNA-690. J Biol Chem 288:36810\u201336826","journal-title":"J Biol Chem"},{"key":"2955_CR176","doi-asserted-by":"publisher","first-page":"18707","DOI":"10.1074\/jbc.M113.545210","volume":"289","author":"X Yang","year":"2014","unstructured":"Yang X, Hegde VL, Rao R et al (2014) Histone modifications are associated with Delta(9)-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses. J Biol Chem 289:18707\u201318718. https:\/\/doi.org\/10.1074\/jbc.M113.545210","journal-title":"J Biol Chem"},{"key":"2955_CR177","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neubiorev.2017.05.011","volume":"85","author":"H Szutorisz","year":"2018","unstructured":"Szutorisz H, Hurd YL (2018) High times for cannabis: epigenetic imprint and its legacy on brain and behavior. Neurosci Biobehav Rev 85:93\u2013101. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.05.011","journal-title":"Neurosci Biobehav Rev"},{"key":"2955_CR178","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.bbrc.2014.08.008","volume":"451","author":"P M\u00f6hnle","year":"2014","unstructured":"M\u00f6hnle P, Sch\u00fctz SV, Schmidt M et al (2014) MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure. Biochem Biophys Res Commun 451:516\u2013521. https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.008","journal-title":"Biochem Biophys Res Commun"},{"key":"2955_CR179","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1128\/JVI.01754-14","volume":"89","author":"LC Chandra","year":"2014","unstructured":"Chandra LC, Kumar V, Torben W et al (2014) Chronic administration of \u03949-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques. J Virol 89:1168\u20131181. https:\/\/doi.org\/10.1128\/JVI.01754-14","journal-title":"J Virol"},{"key":"2955_CR180","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.biopsych.2012.04.026","volume":"72","author":"HC Tomasiewicz","year":"2012","unstructured":"Tomasiewicz HC, Jacobs MM, Wilkinson MB et al (2012) Proenkephalin mediates the enduring effects of adolescent cannabis exposure associated with adult opiate vulnerability. Biol Psychiatry 72:803\u2013810. https:\/\/doi.org\/10.1016\/j.biopsych.2012.04.026","journal-title":"Biol Psychiatry"},{"key":"2955_CR181","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000338642","volume":"19","author":"A Rotter","year":"2013","unstructured":"Rotter A, Bayerlein K, Hansbauer M et al (2013) CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence. Eur Addict Res 19:13\u201320. https:\/\/doi.org\/10.1159\/000338642","journal-title":"Eur Addict Res"},{"key":"2955_CR182","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1002\/eji.201040667","volume":"40","author":"VL Hegde","year":"2010","unstructured":"Hegde VL, Nagarkatti M, Nagarkatti PS (2010) Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties. Eur J Immunol 40:3358\u20133371. https:\/\/doi.org\/10.1002\/eji.201040667","journal-title":"Eur J Immunol"},{"key":"2955_CR183","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1002\/eji.200939892","volume":"39","author":"V Bronte","year":"2009","unstructured":"Bronte V (2009) Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions. Eur J Immunol 39:2670\u20132672. https:\/\/doi.org\/10.1002\/eji.200939892","journal-title":"Eur J Immunol"},{"key":"2955_CR184","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162\u2013174. https:\/\/doi.org\/10.1038\/nri2506","journal-title":"Nat Rev Immunol"},{"key":"2955_CR185","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/glia.23317","volume":"66","author":"M Mecha","year":"2018","unstructured":"Mecha M, Feli\u00fa A, Mach\u00edn I et al (2018) 2-AG limits Theiler\u2019s virus induced acute neuroinflammation by modulating microglia and promoting MDSCs. Glia 66:1447\u20131463. https:\/\/doi.org\/10.1002\/glia.23317","journal-title":"Glia"},{"key":"2955_CR186","doi-asserted-by":"publisher","first-page":"e93954","DOI":"10.1371\/journal.pone.0093954","volume":"9","author":"AR Jackson","year":"2014","unstructured":"Jackson AR, Nagarkatti P, Nagarkatti M (2014) Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction. PLoS One 9:e93954. https:\/\/doi.org\/10.1371\/journal.pone.0093954","journal-title":"PLoS One"},{"key":"2955_CR187","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.reprotox.2010.12.055","volume":"31","author":"F Perera","year":"2011","unstructured":"Perera F, Herbstman J (2011) Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol 31:363\u2013373. https:\/\/doi.org\/10.1016\/j.reprotox.2010.12.055","journal-title":"Reprod Toxicol"},{"key":"2955_CR188","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1089\/jwh.2009.1408","volume":"19","author":"RF Thompson","year":"2010","unstructured":"Thompson RF, Einstein FH (2010) Epigenetic basis for fetal origins of age-related disease. J Womens Health (Larchmt) 19:581\u2013587. https:\/\/doi.org\/10.1089\/jwh.2009.1408","journal-title":"J Womens Health (Larchmt)"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-018-2955-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-018-2955-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-018-2955-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T13:46:40Z","timestamp":1694008000000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-018-2955-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":188,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2955"],"URL":"https:\/\/doi.org\/10.1007\/s00018-018-2955-0","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"16 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}